For head and neck squamous cell carcinoma (HNSCC) [183], HYAL1 demonstrates potential as a tissue-specific biomarker, with elevated HYAL1 and PH20 expression observed in laryngeal carcinoma specimens [184]. This evidence concerns the gene SPAM1 and head and neck squamous cell carcinoma.